Israeli biopharmaceutical firm Mileutis said on Tuesday results from a clinical trial showed that its non-antibiotic substitute to treat infections in cows boosted milk quality in dairy cows.
Mileutis conducted a trial in seven Israeli dairy farms along with Strauss Health, which is partly owned by France’s Danone (DANO.PA). The trial of more than 500 dairy cows was carried out at farms that provide milk to two of Israel’s largest dairy suppliers – Strauss (STRS.TA) and Tnuva, owned by China’s Bright Food and Dairy Co (600597.SS).
